ویرایش:  
 
سری:  
ISBN (شابک) : 9780470673171, 9781118556153 
ناشر: Wiley-Blackwell 
سال نشر: 2013 
تعداد صفحات: 326 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 8 مگابایت 

قیمت کتاب (تومان) : 42,000

Do you have patients referred to you suffering from NAFLD?
Are you looking for an expert guide to the latest in clinical management?

If so, this is the book for you, providing an expert and comprehensive analysis of NAFLD: what it is, why it happens, who is likely to suffer from it, and how to decide on the best management options for your patients.

This book focuses clearly on providing first-rate clinical guidance as to the assessment, diagnosis and treatment of patients in the clinical setting, based wherever possible on the latest evidence and scientific understanding of disease mechanisms.  With each chapter fully revised and updated with the very latest in AASLD,  EASL and Asia-Pacific guidelines, this second edition provides:

• Four brand new chapters, including “NAFLD and cardiovascular risk factors” and “Non-invasive methods to determine severity of NAFLD/ NASH”
• A clear overview on the causative mechanisms of NAFLD
• Self-assessment via key points and multiple-choice questions throughout
• The very latest in clinical drug trials
• Analysis of NAFLD in relation to obesity, diabetes, high cholesterol and liver cancer
• A consideration of NAFLD importance in Asia (particularly including Japan and China) and South America, as well as Europe and North America

NAFLD is a serious condition that is increasing in prevalence globally from year to year.  Non-Alcoholic Fatty Liver Disease: A Practical Guide, 2^nd Edition, is essential reading for all hepatologists and health professionals managing patients who have this condition.Content:
Chapter 1 What is Non?Alcoholic Fatty Liver Disease (NAFLD), and Why is it Important? (pages 1–16): Geoffrey C. Farrell, Arthur J. McCullough and Christopher P. Day
Chapter 2 NAFLD in the Community (pages 17–26): Leon A. Adams
Chapter 3 Pathology of NAFLD (pages 27–36): Elizabeth M. Brunt and David E. Kleiner
Chapter 4 The Natural History of NAFLD (pages 37–45): Paul Angulo
Chapter 5 Emerging Concepts on the Pathogenesis of Non?Alcoholic Steatohepatitis (NASH) (pages 46–61): Isabelle A. Leclercq
Chapter 6 Diabetes and NAFLD: Why is the Connection Important? (pages 62–70): Elisabetta Bugianesi
Chapter 7 NAFLD and Cardiovascular Risk Factors: Implications for Vascular Disease (pages 71–83): Giovanni Targher
Chapter 8 A Primary Care Perspective of Fatty Liver: Diagnosis, Management, Prescribing, and when to Refer (pages 84–92): Shivakumar Chitturi and Geoffrey C. Farrell
Chapter 9 Imaging of NAFLD (pages 93–111): Takeshi Yokoo, An Tang and Claude B. Sirlin
Chapter 10 Non?Invasive Methods to Determine the Severity of NAFLD and NASH (pages 112–121): Vincent Wai?Sun Wong and Henry Lik?Yuen Chan
Chapter 11 Fatigue, Quality of Life, and Psychosocial Issues for People with NAFLD (pages 122–131): Julia L. Newton and James Frith
Chapter 12 Physical Activity and Cardiovascular Fitness in Patients with NAFLD: Clinical Importance and Therapeutic Implications (pages 132–148): Ingrid J. Hickman, Graeme A. Macdonald and Nuala M. Byrne
Chapter 13 NAFLD, Obesity, and Bariatric Surgery (pages 149–156): Philippe Mathurin
Chapter 14 Genetic Predisposition to NAFLD and NASH: Implications for Pathogenesis, Diagnosis, Prevention, and Management (pages 157–170): Quentin M. Anstee, Ann K. Daly and Christopher P. Day
Chapter 15 NAFLD in Children (pages 171–181): Ariel E. Feldstein
Chapter 16 The Pointy End of the NAFLD Iceberg: Cirrhosis, Portal Hypertension, and Liver Failure (pages 182–191): Jonathon W. Schwake, Dawn M. Torres and Stephen A. Harrison
Chapter 17 Non?Alcoholic Fatty Liver Disease, Hepatocellular Cancer, and Other Cancers (pages 192–205): Janine Graham and Helen L. Reeves
Chapter 18 NAFLD in Chinese and South Asian people (pages 206–216): Jia?Horng Kao, Deepak Amarapurkar and Jian?Gao Fan
Chapter 19 Non?Alcoholic Fatty Liver Disease in Japan (pages 217–227): Takeshi Okanoue, Kohichiroh Yasui and Yoshito Itoh
Chapter 20 Non?Alcoholic Fatty Liver Disease in South America and Hispanic people (pages 228–233): Helma Pinchemel Cotrim and Carla Daltro
Chapter 21 Alcohol in Non?Alcoholic Fatty Liver Disease: an Oxymoron or a New Standard of Care? (pages 234–247): Achuthan Sourianarayanane, Srinivasan Dasarathy and Arthur J. McCullough
Chapter 22 Dietary Factors in the Pathogenesis and Care of Patients with Fatty Liver Disease (pages 248–259): Giulio Marchesini, Rebecca Marzocchi, Anna S. Sasdelli, Cristiana Andruccioli and Silvia Di Domizio
Chapter 23 Metabolic Factors and Steatosis in Patients with Hepatitis B and C (pages 260–270): Francesco Negro
Chapter 24 Drug Therapy for NASH: Insulin?Sensitizing Agents (Metformin and Thiazolidinediones) (pages 271–283): Mohammad S. Siddiqui and Arun J. Sanyal
Chapter 25 Hepatoprotectants Against Fatty Liver Disease: Antioxidants, Ursodeoxycholic Acid, and Herbal Medicines (pages 284–292): Anne Catherine Burgi and Jean?Francois Dufour
Chapter 26 Lipid Modifiers and NASH: Statins, Ezetimibe, Fibrates, and Other Agents (pages 293–307): Giovanni Musso, Federica Molinaro, Elena Paschetta, Roberto Gambino and Maurizio Cassader